The metabolic syndrome in type 1 diabetes: does it exist and does it matter?

Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabetic Medicine, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Alexander, 2003, NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older, Diabetes, 52, 1210, 10.2337/diabetes.52.5.1210 Bonora, 2004, The metabolic syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study, Diabetic Medicine, 21, 52, 10.1046/j.1464-5491.2003.01068.x Bruno, 2004, Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study, Diabetes Care, 27, 2689, 10.2337/diacare.27.11.2689 De Block, 2005, Impact of overweight on chronic microvascular complications in type 1 diabetic patients, Diabetes Care, 28, 1649, 10.2337/diacare.28.7.1649 Gale, 2005, The myth of the metabolic syndrome, Diabetologia, 48, 1679, 10.1007/s00125-005-1873-5 Hamilton, 2003, Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial, Diabetes Care, 26, 138, 10.2337/diacare.26.1.138 Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683 Isomaa, 2001, The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes, Diabetologia, 44, 1148, 10.1007/s001250100615 Jefferies, 2004, Potential adjunctive therapies in adolescents with type 1 diabetes mellitus, Treat, 3, 337, 10.2165/00024677-200403060-00002 Kahn, 2005, The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetologia, 48, 1684, 10.1007/s00125-005-1876-2 Libman, 2003, Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes, Diabetes Care, 26, 2871, 10.2337/diacare.26.10.2871 Meyer, 2002, The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients, Diabetes Care, 25, 2153, 10.2337/diacare.25.12.2153 Scuteri, 2005, The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study, Diabetes Care, 28, 882, 10.2337/diacare.28.4.882 Stern, 2005, Identification of individuals with insulin resistance using routine clinical measurements, Diabetes, 54, 333, 10.2337/diabetes.54.2.333 Thorn, 2005, Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study), Diabetes Care, 28, 2019, 10.2337/diacare.28.8.2019 Williams, 2000, Can clinical factors estimate insulin resistance in type 1 diabetes?, Diabetes, 49, 626, 10.2337/diabetes.49.4.626 Williams, 1999, Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study, Diabetes Care, 22, 1084, 10.2337/diacare.22.7.1084